PharmacoEconomics / Springer Healthcare | Adis
Citation Profile [Updated: 2023-11-03 08:28:08]
5 Years H Index
Impact Factor (IF)
0
5 Years IF
0
Data available in this
report
[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
Main indicators
Raw Data
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | Integer/Linear Mathematical Programming Models: A Tool for Allocating Healthcare Resources. (2003). Earnshaw, Stephanie R. ; Dennett, Susan L.. In: PharmacoEconomics. RePEc:wkh:phecon:v:21:y:2003:i:12:p:839-851. Full description at Econpapers || Download paper | 18 | |
| 2 | Having Your Cake and Eating It: Office of Fair Trading Proposal for Funding New Drugs to Benefit Patients and Innovative Companies. (2008). Godman, Brian ; Schwabe, Ulrich ; Garattini, Silvio ; Joppi, Roberta . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:2:p:91-98. Full description at Econpapers || Download paper | 5 | |
| 3 | Cost of Schizophrenia to UK Society: An Incidence-Based Cost-of-Illness Model for the First 5 Years Following Diagnosis. (1999). Guest, Julian F. ; Cookson, Ron F.. In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:6:p:597-610. Full description at Econpapers || Download paper | 3 | |
| 4 | QALYs: Are They Helpful to Decision Makers?. (2006). Caro, Jaime J. ; McGregor, Maurice . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:10:p:947-952. Full description at Econpapers || Download paper | 3 | |
| 5 | Cost-Effectiveness Analysis and the Consistency of Decision Making: Evidence from Pharmaceutical Reimbursement in Australia (1991 to 1996). (2001). Harris, Anthony ; Mitchell, Andrew ; George, Bethan . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:11:p:1103-1109. Full description at Econpapers || Download paper | 2 | |
| 6 | The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?. (2008). Jommi, Claudio . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:1:p:5-15. Full description at Econpapers || Download paper | 2 | |
| 7 | Modelling in Health Economic Evaluation: What is its Place? What is its Value?. (2000). Akehurst, Ron . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:5:p:445-459. Full description at Econpapers || Download paper | 2 | |
| 8 | European Healthcare Policies for Controlling Drug Expenditure. (2003). Schneeweiss, Sebastian ; Szucs, Thomas D. ; Ess, Silvia M.. In: PharmacoEconomics. RePEc:wkh:phecon:v:21:y:2003:i:2:p:89-103. Full description at Econpapers || Download paper | 2 | |
| 9 | NICE Guide to the Methods of Technology Appraisal: Pharmaceutical Industry Perspective. (2008). Lewis, Gavin ; Earnshaw, Julia . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:9:p:725-727. Full description at Econpapers || Download paper | 2 | |
| 10 | Annual Cost of Erectile Dysfunction to UK Society. (1999). Plumb, Jonathan M. ; Guest, Julian F.. In: PharmacoEconomics. RePEc:wkh:phecon:v:16:y:1999:i:6:p:699-709. Full description at Econpapers || Download paper | 1 | |
| 11 | The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4. (2008). Mitchell, Andrew ; Scuffham, Paul A. ; Whitty, Jennifer A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:4:p:297-310. Full description at Econpapers || Download paper | 1 | |
| 12 | Information Created to Evade Reality (ICER): Things We Should Not Look to for Answers. (2006). Gafni, Amiram ; Birch, Stephen . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:11:p:1121-1131. Full description at Econpapers || Download paper | 1 | |
| 13 | Prospective Study Designs in Outcomes Research: The Case of Migraine. (2002). Gomez-Mancilla, Baltazar ; Schonfeld, Warren H. ; Brod, Meryl I. ; Rothermich, Elizabeth A. ; Rowland, Clayton R.. In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:11:p:715-725. Full description at Econpapers || Download paper | 1 | |
| 14 | Cost of Illness in Adult Patients with Hypopituitarism. (2000). Bengtsson, Bengt-Ake ; Rosen, Thord ; Roijen, Leona Hakkaart-van ; Frans F. H. Rutten, ; Ehrnborg, Christer ; Jonsson, Bjorn . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:6:p:621-628. Full description at Econpapers || Download paper | 1 | |
| 15 | Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review. (2010). Puig-Junoy, Jaume . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:8:p:649-663. Full description at Econpapers || Download paper | 1 | |
| 16 | The Burden of Illness of Hypopituitary Adults with Growth Hormone Deficiency. (1998). Stevenaert, Achille ; Roijen, Leona Hakkaart-van ; Frans F. H. Rutten, ; Beckers, Albert . In: PharmacoEconomics. RePEc:wkh:phecon:v:14:y:1998:i:4:p:395-403. Full description at Econpapers || Download paper | 1 | |
| 17 | An Economic Overview of Chronic Obstructive Pulmonary Disease. (2001). Dasbach, Erik J. ; Ruchlin, Hirsch S.. In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:6:p:623-642. Full description at Econpapers || Download paper | 1 | |
| 18 | Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration: Multi-Country Observational Study. (2008). Cruess, Alan F. ; Xu, Xiao ; Knight, Tyler ; Goss, Thomas F. ; Buggage, Ronald ; Mones, Jordi ; Soubrane, Gisele ; Zlateva, Gergana ; Pauleikhoff, Daniel ; Schaefer, Caroline ; Lotery, Andrew . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:1:p:57-73. Full description at Econpapers || Download paper | 1 | |
| 19 | Expert Judgement in Pharmacoeconomic Studies: Guidance and Future Use. (2000). Crawford, Bruce ; Evans, Christopher . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:6:p:545-553. Full description at Econpapers || Download paper | 1 | |
| 20 | The Cost Effectiveness of ACE Inhibitors as First-Line Antihypertensive Therapy. (2003). Nordmann, Alain J. ; Krahn, Murray ; Naglie, Gary ; Detsky, Allan S. ; Logan, Alexander G.. In: PharmacoEconomics. RePEc:wkh:phecon:v:21:y:2003:i:8:p:573-585. Full description at Econpapers || Download paper | 1 | |
| 21 | Cant Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products. (2010). Towse, Adrian ; Garrison, Louis P.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:93-102. Full description at Econpapers || Download paper | 1 | |
| 22 | Does Managed Care Fuel Pharmaceutical Industry Growth?. (1998). Deardorff, Frank W. ; Murray, Michael D.. In: PharmacoEconomics. RePEc:wkh:phecon:v:14:y:1998:i:4:p:341-348. Full description at Econpapers || Download paper | 1 | |
| 23 | Developing Guidance for Budget Impact Analysis. (2001). Hutton, John ; Trueman, Paul ; Drummond, Michael . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:6:p:609-621. Full description at Econpapers || Download paper | 1 | |
| 24 | The Economic Impact of Parkinson`s Disease: An Estimation Based on a 3-Month Prospective Analysis. (1998). Rathay, Bernard ; Oertel, Wolfgang H. ; Szucs, Thomas ; Kohne-Volland, Rudolf ; Dodel, Richard C. ; Singer, Marikka ; Scholz, Erich . In: PharmacoEconomics. RePEc:wkh:phecon:v:14:y:1998:i:3:p:299-312. Full description at Econpapers || Download paper | 1 | |
| 25 | The Cost of Treatment of Alzheimers Disease in The Netherlands: A Regression-Based Simulation Model. (2001). Ruitenberg, Annemieke ; van der Roer, Nicole ; Monique M. B. Breteler, ; Redekop, Ken W. ; McDonnell, Joseph ; Jan J. V. Busschbach, ; Frans F. H. Rutten, ; Goes, Elles . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:4:p:379-390. Full description at Econpapers || Download paper | 1 | |
| 26 | Incorporating Carer Effects into Economic Evaluation. (2006). Walker, Mel ; Dixon, Simon ; Salek, Sam . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:1:p:43-53. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|
Citing documents used to
compute impact factor:
| Year | Title |
|---|
Recent citations
10 most frequent citing series
| # | Series | H | Cites |
|---|